Literature DB >> 4966722

Immune reactions and kinin formation in chronic trypanosomiasis.

P F Boreham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4966722      PMCID： PMC1570314          DOI： 10.1111/j.1476-5381.1968.tb00450.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN： 0366-0826


× No keyword cloud information.
  19 in total

1.  A micromethod for determination of bradykininogen under several conditions.

Authors:  C R DINIZ; I F CARVALHO
Journal:  Ann N Y Acad Sci       Date:  1963-02-04       Impact factor: 5.691

2.  Antigenic analysis in the Trypanosoma brucei group, using the agglutination reaction.

Authors:  M P CUNNINGHAM; K VICKERMAN
Journal:  Trans R Soc Trop Med Hyg       Date:  1962-01       Impact factor: 2.184

3.  The influence of antibody on serological variation in Trypanosoma brucei.

Authors:  A R GRAY
Journal:  Ann Trop Med Parasitol       Date:  1962-04

4.  Studies on bradykinin and bradykininogen in malaria.

Authors:  A Tella; B G Maegraith
Journal:  Ann Trop Med Parasitol       Date:  1966-09

5.  Vascular lesions in rabbits infected with Trypanosoma (Trypanozoon) brucei.

Authors:  L G Goodwin; S V Hook
Journal:  Br J Pharmacol Chemother       Date:  1968-03

Review 6.  Biological aspects of trypanosomiasis research.

Authors:  W H Lumsden
Journal:  Adv Parasitol       Date:  1965       Impact factor: 3.870

Review 7.  The classification of mammalian trypanosomes.

Authors:  C A Hoare
Journal:  Ergeb Mikrobiol Immunitatsforsch Exp Ther       Date:  1966

8.  Pharmacologically active substances in the plasma of guinea-pig infected with Trypanosoma evansi.

Authors:  B K Bhattacharya; A B Sen; V Talwalkar
Journal:  Arch Int Pharmacodyn Ther       Date:  1965-07

9.  Bradykininogen and bradykinin in the cardiovascular shock produced by proteolytic enzymes.

Authors:  A P Corrado; M L Reis; I F Carvalho; C R Diniz
Journal:  Biochem Pharmacol       Date:  1966-07       Impact factor: 5.858

10.  Pharmacologically active peptides produced in the tissues of the host during chronic trypanosome infections.

Authors:  P F Boreham
Journal:  Nature       Date:  1966-10-08       Impact factor: 49.962
View more
  13 in total

1.  Fibrinogen and fibrinogen/fibrin degradation products in the urine of rabbits infected with Trypanosoma (trypanozoon) brucei.

Authors:  P F Boreham; C A Facer
Journal:  Z Parasitenkd       Date:  1977-07-29

2.  Kinin, kininogen and kininase levels during acute Babesia bovis (= B. argentina) infection of cattle.

Authors:  I G Wright
Journal:  Br J Pharmacol       Date:  1977-12       Impact factor: 8.739

3.  Acute Babesia bigemina infection: changes in coagulation and kallikrein parameters.

Authors:  I G Wright; B V Goodger
Journal:  Z Parasitenkd       Date:  1977-08-25

Review 4.  Biologically active products from African Trypanosomes.

Authors:  I Tizard; K H Nielsen; J R Seed; J E Hall
Journal:  Microbiol Rev       Date:  1978-12

5.  Tests for antibody- and cell-mediated hypersensitivity to trypanosome antigens in rabbits infected with Trypanosoma congolense.

Authors:  J M Mansfield; J P Kreier
Journal:  Infect Immun       Date:  1972-07       Impact factor: 3.441

6.  Vascular lesions in rabbits infected with Trypanosoma (Trypanozoon) brucei.

Authors:  L G Goodwin; S V Hook
Journal:  Br J Pharmacol Chemother       Date:  1968-03

7.  In vitro studies on the mechanism of kinin formation by trypanosomes.

Authors:  P F Boreham
Journal:  Br J Pharmacol       Date:  1968-11       Impact factor: 8.739

8.  Changes in intravascular complement, kininogen, and histamine during Jarisch-Herxheimer reaction in secondary syphilis.

Authors:  C Loveday; J S Bingham
Journal:  Genitourin Med       Date:  1985-02

9.  Production of kinins in bovine anaphylactic shock.

Authors:  P Eyre; A J Lewis
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

10.  Acute systemic anaphylaxis in the horse.

Authors:  P Eyre; A J Lewis
Journal:  Br J Pharmacol       Date:  1973-07       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.